PTC Therapeutics Mergers and Acquisitions Summary

Life Science Company

PTC Therapeutics has acquired 3 companies, including 3 in the last 5 years.

PTC Therapeutics’ largest acquisition to date was in 2018, when it acquired Agilis Biotherapeutics for $200M. PTC Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to PTC Therapeutics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 2

PTC Therapeutics, Inc.

100 Corporate Court,
South Plainfield, New Jersey 07080
United States,
(908) 222-7000
www.ptcbio.com

PTC Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology we refer to as post-transcriptional control. PTC Therapeutics was founded in 1998 and is based in South Plainfield, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.6/yr) # - - 1 1 - 1 3
vol $140M $200M $10M $350M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Censa Pharmaceuticals, Inc. 2020-05-06 10M USD Add-on Acquisition
Wellesley, Massachusetts · www.censapharma.com
Agilis Biotherapeutics, Inc. 2018-07-19 200M USD Add-on Acquisition
Cambridge, Massachusetts · www.agilisbio.com
Emflaza 2017-03-16 140M USD Divestiture
Deerfield, Illinois
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 350M (100%) - -
Total 3 $350M - -

By Geo

State/Country Buy Value Sell Value
United States 3 350M - -
  Massachusetts 2 210M - -
  Illinois 1 140M - -
Total 3 $350M - -

Top M&A Advisors

Financial Deals
Evercore Group LLC
1
Legal Deals
Wilmer Cutler Pickering Hale and Dorr LLP
1

Deal Values

buy # Total
$100M to $1B 2 $340M
< $100M 1 $10M
TOTAL $350M
Largest Agilis Biotherapeutics, Inc.
$200M (2018-07-19)

M&A Connections

Deals %
Acquired from
Strategic(s)
100%
1 100%

 Subscribe to unlock this and 153,012
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 141K M&A Transactions
  • 149K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 42K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.